Compare up to 40 stocks
Compared Stocks: 1 / 40
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 RVMD | Healthcare | $172.29 | 2.65M | $38.14B | -18.83 | ― | Strong Buy |
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| RVMD | Revolution Medicines | 172.29 | 104.54 | 154.30% |
| Name | Price | % Change | |
|---|---|---|---|
| RVMD | $172.29 | +154.30% |
Morgan Stanley analyst Sean Laaman lowered the firm’s price target on Revolution Medicines (RVMD) to $247 from $272 and keeps an Overweight rating on the shares. The firm adjusted estimates
H.C. Wainwright analyst Robert Burns raised the firm’s price target on Revolution Medicines (RVMD) to $350 from $280 and keeps a Buy rating on the shares. The firm says Rasonque
Morgan Stanley raised the firm’s price target on Revolution Medicines (RVMD) to $272 from $255 and keeps an Overweight rating on the shares. Rasonque’s first commercial quarter came in well
RBC Capital raised the firm’s price target on Revolution Medicines (RVMD) to $321 from $260 and keeps an Outperform rating on the shares. The Rasonque launch far exceeded RBC’s expectations,
TD Cowen raised the firm’s price target on Revolution Medicines (RVMD) to $270 from $250 and keeps a Buy rating on the shares. Rasonque’s $198MM sales from 5 weeks in
Guggenheim raised the firm’s price target on Revolution Medicines (RVMD) to $298 from $275 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source
Evercore ISI analyst Cory Kasimov raised the firm’s price target on Revolution Medicines (RVMD) to $340 from $320 and keeps an Outperform rating on the shares. Published first on TheFly
BofA raised the firm’s price target on Revolution Medicines (RVMD) to $274 from $264 and keeps a Buy rating on the shares. Published first on TheFly – the ultimate source
Piper Sandler raised the firm’s price target on Revolution Medicines (RVMD) to $222 from $210 and keeps an Overweight rating on the shares. The firm notes the company reported Q3
S&P 500 rallied by 1.5% and Dow Industrials was up a whopping 3% on post-election Wednesday, jumping to its highest level in two months. Concerns over the slowdown of the
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| RVMD | buy | Reiterated | Nov 13, 2026 | |||
| RVMD | buy | Reiterated | Nov 12, 2026 | |||
| RVMD | buy | Reiterated | Nov 9, 2026 | |||
| RVMD | buy | Reiterated | Nov 9, 2026 | |||
| RVMD | buy | Reiterated | Nov 6, 2026 | |||
| RVMD | buy | Assigned | Nov 5, 2026 | |||
| RVMD | buy | Reiterated | Nov 5, 2026 | |||
| RVMD | buy | Reiterated | Nov 5, 2026 | |||
| RVMD | buy | Reiterated | Nov 5, 2026 | |||
| RVMD | buy | Assigned | Nov 5, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| RVMD | Mar 1, 2027TBA | $38.14B | $-1.16 | $403.38M | -0.20 | -18.83 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
